Although current allergen immunotherapy is an effective method of treating allergic inflammation, it is time consuming and carries the risk of anaphylaxis. Novel therapies for treating allergic inflammation are of two general types. In one senario, a key factor in the allergic cascade is blocked. The other possibility is to modify current immunotherapy administration.
|Original language||English (US)|
|Number of pages||5|
|Journal||Allergy and Asthma Proceedings|
|State||Published - Nov 1 2002|
ASJC Scopus subject areas
- Immunology and Allergy
- Pulmonary and Respiratory Medicine